Michael Peluso, MD
Michael Peluso, MD
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Interleukin-15 to Promote Post-ART Control of HIV | HIV | Enrolling by invitation | Phase 2 | 2026-01-22 | NCT07145164 | |
| Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 2 | 2025-10-28 | NCT05877508 |